Introduction There is certainly paucity of data linked to potential gender differences in the usage of interventions to avoid and treat coronary disease (CVD) among HIV\positive individuals. 1.28 [1.21, 1.35] vs. 2.40 [2.34, 2.46]; ACEIs: 0.88 [0.82, 0.93] vs. 1.43 [1.39, 1.48]; anti\hypertensives: 1.40 [1.33, 1.47] vs. 1.72 [1.68, 1.77] and ICPs: 0.08 [0.06, 0.10]… Continue reading Introduction There is certainly paucity of data linked to potential gender